Ube
4208.TChemicals
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥154.8bn | ¥162.1bn | ¥164.0bn | ¥182.4bn | ¥274.8bn | ¥242.5bn |
| Operating income | ¥3.1bn | ¥1.0bn | ¥7.7bn | ¥10.6bn | ¥14.4bn | ¥8.0bn |
| Ordinary income | ¥25.2bn | ¥22.4bn | ¥20.5bn | ¥23.7bn | ¥28.1bn | ¥13.5bn |
| Total assets | ¥607.3bn | ¥637.1bn | ¥463.6bn | ¥450.6bn | ¥485.4bn | ¥496.9bn |
| Net assets / equity | ¥216.3bn | ¥202.9bn | ¥203.2bn | ¥193.8bn | ¥184.1bn | ¥184.4bn |
| EPS (basic) | ¥228.56 | ¥100.4 | ¥170.08 | ¥197.04 | ¥217.38 | ¥132.24 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 14
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 211 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 73 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 211 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 74 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 212 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 74 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 74 figures · EDINET |
| 2022-04-01 → 2023-03-31 | AnnualAmended | 212 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 73 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 212 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 75 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 75 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 74 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 213 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| High Performance Urethans | ¥46.1bn | −¥548m |
| Machinery | ¥68.1bn | ¥6.2bn |
| Pharmaceutical | ¥20.6bn | −¥1.3bn |
| Polymers And Chemicals | ¥228.4bn | ¥8.2bn |
| Specialty Products | ¥50.9bn | ¥9.8bn |
| Other segments | ¥48.1bn | ¥1.9bn |
| Adjustments & eliminations | — | −¥5.4bn |
| Total | ¥462.3bn | ¥24.3bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.